FDA Clears T2 Biosystems’ Key Update in Sepsis Battle
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
- Latest
- Trending
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
Investment firm Jefferies maintains its Buy rating on Vestis Corp, highlighting its well-executed turnaround strategy and potential for margin improvement ...
Deutsche Bank downgrades Masonite International's stock rating and increases price target, citing promising benefits from the recent agreement with Owens ...
UBS upgrades GE HealthCare Technologies to Neutral, raises price target to $88. Positive outlook for company's margin improvement and revenue ...
UBS predicts S&P 500 will reach 5,300, exceeding 7% growth rate. Positive earnings and economic outlook contribute to optimistic market ...
Mining billionaire Robert Friedland's company, HPX, is partnering with Liberia's government and Guma Africa Group for a $5 billion infrastructure ...
Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion to expand its liver disease portfolio, including access to potential treatment for ...
Investment firm Piper Sandler has upgraded Cass Information Systems' rating to Overweight and increased its price target. Analysts are optimistic ...
Shares of TOP Financial Group Ltd. tumbled 12.2% in premarket trading today after a surge on Friday. The stock's volatility ...
PepsiCo lowers organic sales growth forecast, but Citi upgrades stock rating and raises price target due to positive market expectations.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.